BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38884843)

  • 21. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
    Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
    Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
    Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
    Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
    Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity.
    Filippi CM; Juedes AE; Oldham JE; Ling E; Togher L; Peng Y; Flavell RA; von Herrath MG
    Diabetes; 2008 Oct; 57(10):2684-92. PubMed ID: 18689691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.
    Sievers C; Craveiro M; Friedman J; Robbins Y; Yang X; Bai K; Nguyen A; Redman JM; Chari R; Soon-Shiong P; Schlom J; Gulley J; Allen CT
    Cancer Cell; 2023 May; 41(5):887-902.e5. PubMed ID: 37059104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Potential Markers of Regulatory and Exhausted CD8
    Naghavi Alhosseini M; Palazzo M; Cari L; Ronchetti S; Migliorati G; Nocentini G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.
    Terabe M; Ambrosino E; Takaku S; O'Konek JJ; Venzon D; Lonning S; McPherson JM; Berzofsky JA
    Clin Cancer Res; 2009 Nov; 15(21):6560-9. PubMed ID: 19861451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.
    Hu Y; Hudson WH; Kissick HT; Medina CB; Baptista AP; Ma C; Liao W; Germain RN; Turley SJ; Zhang N; Ahmed R
    J Exp Med; 2022 Oct; 219(10):. PubMed ID: 35980386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.
    Dodagatta-Marri E; Ma HY; Liang B; Li J; Meyer DS; Chen SY; Sun KH; Ren X; Zivak B; Rosenblum MD; Headley MB; Pinzas L; Reed NI; Del Cid JS; Hann BC; Yang S; Giddabasappa A; Noorbehesht K; Yang B; Dal Porto J; Tsukui T; Niessen K; Atakilit A; Akhurst RJ; Sheppard D
    Cell Rep; 2021 Jul; 36(1):109309. PubMed ID: 34233193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
    Zhang L; Yu Z; Muranski P; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
    Gene Ther; 2013 May; 20(5):575-80. PubMed ID: 22972494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Road Less Taken: Less Appreciated Pathways for Manipulating CD8
    Pichler AC; Cannons JL; Schwartzberg PL
    Front Immunol; 2022; 13():926714. PubMed ID: 35874734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and Molecular Mechanisms of CD8
    Verdon DJ; Mulazzani M; Jenkins MR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.
    Ishigame H; Mosaheb MM; Sanjabi S; Flavell RA
    J Immunol; 2013 Jun; 190(12):6340-50. PubMed ID: 23686479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8+ T-cell memory in tumor immunology and immunotherapy.
    Klebanoff CA; Gattinoni L; Restifo NP
    Immunol Rev; 2006 Jun; 211():214-24. PubMed ID: 16824130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo.
    Tinoco R; Alcalde V; Yang Y; Sauer K; Zuniga EI
    Immunity; 2009 Jul; 31(1):145-57. PubMed ID: 19604493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.
    Chandran PA; Keller A; Weinmann L; Seida AA; Braun M; Andreev K; Fischer B; Horn E; Schwinn S; Junker M; Houben R; Dombrowski Y; Dietl J; Finotto S; Wölfl M; Meister G; Wischhusen J
    J Leukoc Biol; 2014 Oct; 96(4):633-45. PubMed ID: 25030422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.